Mizuho Medy Co.,Ltd. (TYO:4595)

Japan flag Japan · Delayed Price · Currency is JPY
1,775.00
-8.00 (-0.45%)
Apr 28, 2026, 3:30 PM JST
17.94%
Market Cap 33.81B
Revenue (ttm) 11.26B
Net Income (ttm) 3.43B
Shares Out 19.05M
EPS (ttm) 179.80
PE Ratio 9.87
Forward PE n/a
Dividend 100.00 (5.62%)
Ex-Dividend Date Jun 29, 2026
Volume 74,700
Average Volume 69,600
Open 1,783.00
Previous Close 1,783.00
Day's Range 1,772.00 - 1,789.00
52-Week Range 1,402.00 - 1,930.00
Beta 0.50
RSI 37.98
Earnings Date May 8, 2026

About Mizuho Medy

Mizuho Medy Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products, and related scientific and technical information services in Japan. The company offers molecular diagnostic products, such as nucleic acid amplification test products comprising gene analysis instruments and mycoplasma pneumoniae nucleic acid kits. It also provides rapid immunoassay products, including influenza virus antigen test kit; RS virus and human metapneumovirus antigen test kit; streptococcus pneumoniae antigen and legio... [Read more]

Sector Healthcare
Founded 1977
Employees 193
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4595
Full Company Profile

Financial Performance

In 2025, Mizuho Medy's revenue was 11.26 billion, a decrease of -1.48% compared to the previous year's 11.43 billion. Earnings were 3.43 billion, a decrease of -9.22%.

Financial Statements

News

There is no news available yet.